Table 3.
Multivariate-adjusted model of the association between log-transformed urinary cGMP/Cr and VEGF inhibitor
Covariates included in model | β Coefficient for VEGF inhibitor use | p value for VEGF inhibitor use |
---|---|---|
VEGF inhibitor use | −0.30 | 0.018 |
VEGF inhibitor use + age | −0.30 | 0.014 |
VEGF inhibitor use, age, prior HTN, ACE-inhibitor | −0.32 | 0.013 |
VEGF inhibitor use, age, prior HTN, ACE-inhibitor, nephrectomy | −0.24 | 0.047 |
cGMP/Cr denotes cyclic GMP:creatinine ratio; VEGF, vascular endothelial growth factor; HTN, hypertension; ACE, angiotensin-converting enzyme